GoodRx(GDRX)

Emerging#14 in Healthcare

NASDAQ-listed (GDRX) prescription savings platform comparing prices across 70K+ pharmacies; $750M revenue with stock under pressure from Amazon Pharmacy and Cost Plus Drugs competition.

Prescription Savings
GDRX
Visit Website
Updated March 2026

Company Overview

About GoodRx

GoodRx is a Santa Monica-based prescription savings and healthcare price comparison platform that enables consumers to compare prices, access discount coupons, and find the lowest-cost pharmacy for their prescriptions — providing free price comparison tools across 70,000+ US pharmacies and a GoodRx Gold subscription ($9.99/month) with even lower prices on 1,000+ common medications. Listed on NASDAQ (NASDAQ: GDRX), GoodRx went public in September 2020 and generates approximately $750 million in annual revenue primarily from pharmaceutical industry fees and consumer subscription revenue.

Business Model & Competitive Advantage

GoodRx's business model is a three-sided marketplace: consumers use GoodRx to find the lowest price pharmacy and receive a GoodRx coupon (presented at the pharmacy counter or via app at the pharmacy register); the pharmacy bills GoodRx's pharmacy benefit manager (PBM) partner rather than the consumer's insurance; the PBM processes the claim at the negotiated GoodRx contract price and pays GoodRx a fee per transaction. GoodRx's value is the price aggregation across PBM contracts — the same drug can have dramatically different prices across different PBMs and pharmacies, and GoodRx always shows the lowest available.

Competitive Landscape 2025–2026

In 2025, GoodRx (NASDAQ: GDRX) competes in the prescription savings and pharmaceutical price transparency market with RxSaver, Blink Health, Mark Cuban's Cost Plus Drugs (a direct pharmaceutical purchasing model at cost + 15% markup), and Amazon Pharmacy for prescription cost reduction. GoodRx stock declined significantly from its $46 IPO price — trading around $4-7 in 2024-2025 — reflecting revenue headwinds from PBM renegotiations and competition from Amazon Pharmacy and Cost Plus Drugs. Amazon Pharmacy has been particularly disruptive as it offers comparable pricing with the convenience of Amazon delivery. The 2025 strategy focuses on the GoodRx Gold subscriber base, telehealth services that extend beyond prescription savings, and the pharmaceutical manufacturer savings program business (patient assistance programs) as revenue diversification beyond the PBM coupon model.

Revenue
$750M
Curated content • Fact-checked and verified
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

GoodRx is an emerging player bringing innovative solutions to the Healthcare market.

Growth Stage

GoodRx has achieved $750M in revenue, demonstrating strong product-market fit.

Frequently Asked Questions

Not So Random Others

Brisk

Consumer Food & Beverage
B2cManufacturingNorth AmericaFortune500

Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione

Altria

Consumer Goods
B2cManufacturingNorth AmericaPublicFortune500

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s

Chick-fil-A

Consumer Food & Beverage
B2cServicesNorth AmericaEnterprise

Chick-fil-A is the largest US quick-service chicken restaurant chain, generating over $22 billion in annual system-wide sales from approximately 3,000 locations — more revenue per restaurant than any

Yoneda Labs

Healthcare
HealthtechB2bNorth America

Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists wit

Hey Telo

Home Services
B2cMarketplaceServices

Hey Telo is a Berlin-based AI voice agent company building phone-answering and administrative automation specifically for Germany's 1 million+ independent craftsman businesses (Handwerksbetriebe) — HV

H&M (Hennes & Mauritz)

retail
B2cRetailtechPublicGlobalEurope

H&M Hennes & Mauritz is a Swedish multinational fashion retailer founded in 1947, operating brands including H&M, COS, & Other Stories, ARKET, and Weekday. The company runs approximately 4,100 stores

Compare GoodRx with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For GoodRx

Claim This Profile

Are you from GoodRx? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim GoodRx Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention GoodRx vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →